Dabxiga 110mg Capsule
Marketer
Lupin Ltd
Salt Composition
Dabigatran Etexilate (110mg)
Overview Dabxiga 110mg Capsule
Xigduo 110mg capsules function as an anticoagulant, preventing and treating blood clots to mitigate stroke and heart attack risk. This medication inhibits clot formation in leg, lung, brain, and heart veins. Frequently prescribed for patients with atrial fibrillation to prevent thrombosis, it also lowers clot risk post-knee or hip replacement. Administration is independent of meals, though consistent daily timing is recommended. Long-term, potentially lifelong, use may be necessary; cessation or dosage alteration requires physician consultation to avoid increased stroke, heart attack, or thrombosis risk. Lifestyle modifications, including smoking cessation, healthy eating, regular exercise, and weight management (if needed), further reduce clot risk. Common side effects include gastrointestinal upset and increased bleeding susceptibility (e.g., nosebleeds, bruising). Report any adverse effects promptly. Additional potential side effects comprise headaches, seizures, allergic reactions, visual disturbances, and fatigue. Contraindications include severe hepatic or renal impairment, active bleeding, and concomitant use of other anticoagulants. Breastfeeding is not advised during treatment. Unlike some anticoagulants, routine PT-INR monitoring isn't needed.
Primary Ingredients of Dabxiga 110mg Capsule
No text was provided to rewrite.
Uses of Dabxiga 110mg Capsule
Managing and averting blood clot formation.
Major Benefits of Dabxiga 110mg Capsule:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Dabxiga 110mg Capsules can be administered with or without food, though consistent timing is recommended.
Common Side effects of Dabxiga 110mg Capsule:
- Nausea
- Anemia (low number of red blood cells)
- Gastrointestinal bleeding
- Dyspepsia
- Diarrhea
- Abdominal pain
- Nosebleeds
- Skin bleeding
How to use Dabxiga 110mg Capsule:
Follow your doctor's instructions precisely regarding dosage and treatment length for Dabxiga 110mg Capsules. These capsules can be administered with or without food, though consistent timing is recommended.
How Dabxiga 110mg Capsule works:
Xarelto 110mg capsules represent a new class of oral blood thinners. Their mechanism of action involves inhibiting blood clot development.
SAFETY ADVICE
AlcoholUNSAFE
Concurrent alcohol use with Dabxiga 110mg capsules is contraindicated.
PregnancyCONSULT YOUR DOCTOR
The use of Dabxiga 110mg capsules during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. Prescribing physicians will assess the advantages against possible hazards before recommending this medication. Patient consultation with their physician is advised.
Breast feedingCONSULT YOUR DOCTOR
The use of Dabxiga 110mg capsules while breastfeeding is likely inadvisable. Preliminary data from human studies indicate potential transfer of the medication into breast milk, posing a possible risk to the infant.
DrivingSAFE
Driving ability is typically unaffected by taking a 110mg Dabxiga capsule.
KidneyCAUTION
Patients with severe kidney impairment should exercise caution when using Dabxiga 110mg capsules; dosage modification may be necessary. Consult your physician before use. Dabxiga 110mg capsules are not advised for individuals with severe kidney disease.
LiverCAUTION
Patients with hepatic impairment should exercise caution when using Dabxiga 110mg capsules. Dosage modification may be necessary. Physician consultation is advised.
What if you forget to take Dabxiga 110mg Capsule :
Should you forget a Dabxiga 110mg Capsule dose, administer it as promptly as possible that same day. However, omit the missed dose if ingestion is impossible at least six hours prior to your next planned dose. Never compensate for a missed dose by taking a double dose.
Facts to Know About Dabxiga 110mg Capsule
| Label | Value |
|---|---|
| Chemical Classification | Benzimidazole-based compound |
| Developing Habits | No. |
| Treatment Category | Heart |
| Actions | Oral direct thrombin inhibitor |



